(5Z)-11α-ヒドロキシ-9,15-ジオキソプロスタ-5-エン-1-酸 化学特性,用途語,生産方法
説明
13,14-dihydro-15-keto Prostaglandin E
2 (13,14-dihydro-15-keto PGE
2) is a metabolite of PGE
2 and the primary PGE
2 metabolite in plasma. It is formed from PGE
2 via a 15-keto PGE
2 intermediate by 15-oxo-PG Δ
13 reductase. Unlike PGE
2, 13,14-dihydro-15-keto PGE
2 does not bind effectively to the PGE
2 receptors EP
2 and EP
4 expressed in CHO cells (K
is = 12 and 57 μM, respectively) or induce adenylate cyclase activity in the same cells (EC
50s = >18 and >38 μM, respectively). Levels of 13,14-dihydro-15-keto PGE
2 are increased in the plasma of women in the third trimester of pregnancy and in women during and immediately after labor and delivery. Levels of 13,14-dihydro-15-keto PGE
2 levels are decreased in tumor tissue compared to adjacent non-cancerous tissue isolated from patients with non-small cell lung cancer (NSCLC).
使用
13,14-Dihydro-15-ketoPGE2 is a primary metabolite of PGE2 in plasma.
定義
ChEBI: The 13,14-dihydro derivative of 15-oxo-prostaglandin E2.
(5Z)-11α-ヒドロキシ-9,15-ジオキソプロスタ-5-エン-1-酸 上流と下流の製品情報
原材料
準備製品